Aresu, Luca

Beaufils, F

Bertoni, F.

Cascione, L

Cmiljanovic, V

Fabbro, D

Gaudio, E

Hillmann, P

Kwee, I

Rageot, D

Sartori, G

Spriano, F

Stathis, A

Tarantelli, C

Wymann, Mp

Zucca, E

English

Institutional Research Information System University of Turin

The Novel TORC1/2 Kinase Inhibitor PQR620 Has Anti-Tumor Activity in Lymphomas as a Single Agent and in Combination with Venetoclax

https://iris.unito.it/bitstream/2318/1747661/1/The%20Novel%20TORC1%3a2%20Kinase%20Inhibitor%20PQR620%20Has%20Anti-Tumor%20Activity%20in%20Lymphomas%20as%20a%20Single%20Agent%20and%20in%20Combination%20with%20Venetoclax%20.pdf

The Novel TORC1/2 Kinase Inhibitor PQR620 Has Anti-Tumor Activity in Lymphomas as a Single Agent and in Combination with Venetoclax

Abstract

Similar works

Full text

Available Versions

Institutional Research Information System University of Turin